

Greetings

Aging control and overcoming intractable diseases are major challenges in an aging society.
Developed countries, including Japan, are facing an aging society with a declining birthrate.
To address the issue of healthy and long life, our company has been conducting research on regenerative medicine that does not use stem cells.
As a company at the forefront of stem cell culture research, we have obtained numerous international patents and have made it possible to mass-produce safe and homogeneous stem cell culture supernatant as a Japan-originated technology.
We meet a wide range of needs from familiar regenerative medicine to keep you healthy and young to advanced regenerative medicine to overcome intractable diseases.
Representative Director Yasuhiro Yamashita

Company Profile
Company Name | Cysay Inc. |
---|---|
Establishment | February, 2012 |
Representative Director | Yasuhiro Yamashita |
Business activities | Research and development of immortalized cells and cultured supernatants, drug discovery business, sales of food and cosmetic ingredients |
Head Quarter | 5F, 5-1-5, Toranomon, Minato, Tokyo 105-0001 Japan |
Tel | +81-(0)3-6411-9013 |
Capital | 118 million yen |
Number of employees | 15 |
Board of Directors | Board of Directors Michiyo Yamashita Ryo Okada Director (Outside) Masatoshi Ishikawa Masayuki Kimura Masaki Murata Munehisa Kaneda Corporate Auditor Masashi Kikuchi Auditor (part-time) Chihaya Konno |
Attorney at Law | Legal Advisor of TMI Sogo Law Office Shinohara Sogo Law Office |
Patent Attorney | Patent Attorney Advisor Ayafune International Patent Firm |
History
In 2012 |
|
---|---|
In 2013 |
|
In 2014 | Diabetes clinical research begins with South Tohoku Hospital Group |
In 2016 | Saitama University “Molecular Targeted Capsule” research begins |
In 2017 | Started joint research with Tokyo Medical University “Stem Cell Culture Protocol” and “Cytokine Analysis |
In 2018 | Test marketing ends, ODM/OEM orders begin |
In 2019 | Start of raw material supply |
In 2020 | Relocation of Cysay Inc. headquarters to Toranomon, Minato-ku, Tokyo |
In 2023 |
|
In 2024 |
|